会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • MULTIPLEXED ANALYSIS BY CHROMATOGRAPHIC SEPARATION OF MOLECULAR TAGS
    • 通过分子标记的色谱分离进行多重分析
    • WO03042398A2
    • 2003-05-22
    • PCT/US0235864
    • 2002-11-08
    • ACLARA BIOSCIENCES INC
    • CHENNA AHMEDMATRAY TRACYHERNANDEZ VINCENTHOOPER HERBERTSINGH SHARAT
    • C12Q1/68G01N30/02C12Q
    • C12Q1/6809G01N2030/027C12Q2565/102C12Q2565/137
    • Methods and kits are disclosed for determining, either in a homogeneous or heterogeneous assay format, one or more target analytes in a sample using binding compositions coupled to molecular tags by cleavable linkages. Generally, an assay mixture is formed comprising a sample and a reagent comprising multiple such binding compositions under conditions that permit stable complexes to form between the binding compositons and analytes. In one aspect of the invention, the interaction between the binding compositions and their respective binding sites brings a cleavage-inducing moiety into close proximity to cleavable linkages or provides a recognizable substrate for a cleavage-inducing moiety. In this way, one or more molecular tags for each of the analytes are released from the complexes. Released molecular tags are chromatographically separated and the presence and/or amount of the target analytes are determined based on the analysis of the released and separated molecular tags.
    • 公开了用于以同质或非均相测定形式测定样品中一种或多种目标分析物的方法和试剂盒,其使用通过可切割键连接分子标签的结合组合物。 通常,在允许在结合组合物和分析物之间形成稳定的复合物的条件下,形成包含样品和包含多种这样的结合组合物的试剂的测定混合物。 在本发明的一个方面,结合组合物和它们各自的结合位点之间的相互作用使切割诱导部分靠近可裂解连接,或为切割诱导部分提供可识别的底物。 以这种方式,每个分析物的一个或多个分子标签从配合物中释放出来。 释放的分子标签被色谱分离,并且基于释放和分离的分子标签的分析确定靶分析物的存在和/或量。
    • 4. 发明申请
    • METHODS FOR SINGLE NUCLEOTIDE POLYMORPHISM DETECTION
    • 单核苷酸多态性检测方法
    • WO0056925A3
    • 2002-04-11
    • PCT/US0006135
    • 2000-03-08
    • ACLARA BIOSCIENCES INC
    • SINGH SHARATULLMAN EDWIN F
    • C12Q1/68
    • C12Q1/6858C12Q1/6869C12Q2565/30C12Q2565/125C12Q2563/149C12Q2523/319C12Q2523/107
    • Methods and compositions are provided for determining large numbers of single nucleotide polymorphisms in target DNA employing particles having (1) primers complementary to sequences in the target DNA where the next succeeding 3'-nucleotide is a potential single nucleotide polymorphism and coding composition members, where the members are unique for each primer, and (2) differentially labeled terminating nucleotides, where the label permits separation of the terminating nucleotides. Desirably the particles are separated into groups having a common prevalent next succeeding nucleotide. The particles and target DNA are combined under nucleotide extending conditions, the particles separated into groups in accordance with the terminating nucleotide and the coding members identified, so that one knows the sequence and the single nucleotide polymorophism. Various protocols are provided for the determination.
    • 提供了用于使用具有(1)与目标DNA中的序列互补的引物,其中下一个后续的3'-核苷酸是潜在的单核苷酸多态性和编码组成成员的粒子来确定靶DNA中大量单核苷酸多态性的方法和组合物,其中 成员对于每个引物是独特的,和(2)差异标记的终止核苷酸,其中标记允许分离终止的核苷酸。 理想地,将颗粒分离成具有普通的下一个后续核苷酸的基团。 颗粒和靶DNA在核苷酸延伸条件下合并,根据终止的核苷酸和鉴定的编码成员将颗粒分成组,以便人们知道序列和单核苷酸多形性。 提供了各种协议用于确定。
    • 7. 发明申请
    • INTRACELLULAR COMPLEXES AS BIOMARKERS
    • 细胞内复合物作为生物标志物
    • WO2004087887A2
    • 2004-10-14
    • PCT/US2004009805
    • 2004-03-30
    • ACLARA BIOSCIENCES INCSINGH SHARATBADAL M YOUSSOUFJIN XUENGUANGSALIMI-MOOSAVI HOSSEIN
    • SINGH SHARATBADAL M YOUSSOUFJIN XUENGUANGSALIMI-MOOSAVI HOSSEIN
    • A61B20060101C07K16/28C12N20060101C12Q3/00G01N33/542G01N33/543G01N33/574C12N
    • G01N33/57492C07K16/2863G01N33/542G01N2333/485G01N2800/52
    • The invention provides a method for determining a disease status of a patient by measuring expression levels of selected intracellular complexes. In one aspect of the invention, the activation status of apoptotic pathways in a patient sample is determined by measuring relative amounts of protein-protein complexes that are characteristic of the apoptotic pathways. In particular, the invention provides a method of determining the activation status of the mitochondrial apoptotic pathway by simultaneously measuring relative amounts of complexes between 14-3-3 proteins and BAD proteins on the one hand and complexes of Bcl-2 proteins and BAD proteins on the other hand. Preferably, methods of the invention are implemented by using sets of binding compounds having releasable molecular tags that are specific for multiple components of one or more complexes formed within apoptotic pathways. After binding molecular tags are released and separated from the assay mixture for analysis.
    • 本发明提供了一种通过测量所选细胞内复合物的表达水平来确定患者的疾病状态的方法。 在本发明的一个方面,通过测量凋亡通路特征的蛋白质 - 蛋白质复合物的相对量来确定患者样品中凋亡途径的活化状态。 特别地,本发明提供了一种通过同时测量14-3-3蛋白和BAD蛋白之间的复合物的相对量以及Bcl-2蛋白和BAD蛋白的复合物的相对量来确定线粒体凋亡途径的激活状态的方法 另一方面。 优选地,本发明的方法通过使用具有可释放分子标签的结合化合物组来实现,所述可释放分子标签对在凋亡途径内形成的一种或多种复合物的多种组分是特异性的。 结合分子标签后,从测定混合物中分离出分子标签进行分析。
    • 8. 发明申请
    • CELL-SCREENING ASSAY AND COMPOSITION
    • 细胞筛选测定和组成
    • WO03006947A3
    • 2003-05-08
    • PCT/US0221339
    • 2002-07-05
    • ACLARA BIOSCIENCES INCSINGH SHARATCHAN-HUI PO-YING
    • SINGH SHARATCHAN-HUI PO-YING
    • G01N33/50G01N33/58C12Q1/66C07H21/02C07H21/04C12N9/12C12P21/06G01N27/26
    • G01N33/5023G01N33/5008G01N33/581
    • The present invention discloses methods for multiplexed cellular assays. The methods can be used for a simultaneous quantitation of transcription levels from multiple promoters, multiple drugs, or for monitoring effects on multiple protein-protein interactions. These methods make use of reporter gene constructs that couple a single reporter enzyme coding sequence with one or more promoter regions, and a set of probes that are subject to degradation by the reporter enzyme, producing a set of reporters that can be separated from each other by differences in their mobilities. Multiplexed assays are achieved by combining a set of cell populations, wherein each population contains a distinct reporter gene construct and a distinct probe. Various treatments are then carried out on the mixture of cells. Treatments that induce transcription from specific promoters will cause synthesis of the reporter enzyme in that particular cell population, leading to degradation of the corresponding probe. The generation of specific reporters is determined by electrophoresis, or other means of measuring mobility, and is correlated with an effect of the treatment on transcription from a defined promoter.
    • 本发明公开了用于多路复用细胞分析的方法。 该方法可用于同时定量多种启动子,多种药物的转录水平,或用于监测对多种蛋白质 - 蛋白质相互作用的影响。 这些方法利用将单个报道酶编码序列与一个或多个启动子区偶联的报道基因构建体和一组受到报道酶降解的探针,产生一组可以彼此分离的报道分子 通过其流动性的差异。 通过组合一组细胞群实现复合测定,其中每个群包含独特的报道基因构建体和独特的探针。 然后对细胞混合物进行各种处理。 诱导特定启动子转录的处理将引起该特定细胞群中报道酶的合成,导致相应探针的降解。 特定报道分子的产生通过电泳或其他测量流动性的手段来确定,并与治疗对来自确定的启动子的转录的影响相关。